Filing Details
- Accession Number:
- 0001864317-23-000001
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-26 18:01:28
- Reporting Period:
- 2023-09-26
- Accepted Time:
- 2023-09-26 18:01:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1677077 | Alzamend Neuro Inc. | ALZN | Pharmaceutical Preparations (2834) | 811822909 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1864317 | J David Katzoff | 940 South Coast Drive Suite 200 Costa Mesa CA 92626 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-09-26 | 53,000 | $0.19 | 81,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The common stock was bought by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $0.1931. The range of purchase prices on the transaction date was $0.19 to $0.1955 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares bought at each price.
Billionaire Hedge Funds
